Aggressive approach and outcome in patients presenting atrial fibrillation and hypertension

Alberto Conti1, Erica Canuti, Yuri Mariannini

  • 1Emergency Medicine, Department of Medical and Surgical Critical Care, University of Florence and Careggi University Hospital, Florence, Italy. aaaconti@hotmail.com

Insights

An aggressive treatment approach for atrial fibrillation (AF) and hypertension improved rhythm control and significantly reduced hospital admissions by 60%. Early intervention for AF lasting less than 48 hours yielded the best outcomes.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Atrial fibrillation (AF) and hypertension are common cardiovascular conditions.
  • Effective management of AF, particularly in hypertensive patients, is crucial for improving patient outcomes.
  • Rhythm control and reducing hospital admissions are key goals in AF management.

Purpose of the Study:

  • To evaluate the effectiveness of an aggressive pharmacological and electrical approach in patients with atrial fibrillation and hypertension.
  • To compare rhythm conversion rates and hospital admission reductions between standard and aggressive treatment strategies.
  • To identify predictors of successful rhythm conversion and hospitalization in this patient cohort.

Main Methods:

  • A comparative study involving 1739 hypertensive patients with AF, divided into standard (n=591) and aggressive (n=1148) treatment groups.
  • The aggressive group received enhanced pharmacological and electrical interventions.
  • Primary endpoint was rhythm conversion; secondary endpoints included conversion modalities and admission rates.

Main Results:

  • The aggressive approach significantly improved overall rhythm conversion rates from 55% to 62% (p=0.018).
  • In patients with AF duration less than 48 hours, rhythm conversion was achieved in 89%, with a preference for class 1C antiarrhythmic drugs.
  • Hospital admissions were reduced by 60%, with 29% of patients in the aggressive group requiring admission versus 50% in the standard group (p<0.001).

Conclusions:

  • An aggressive treatment strategy for AF in hypertensive patients significantly enhances rhythm conversion.
  • Early intervention in AF (duration < 48 hours) with class 1C antiarrhythmics is highly effective for achieving sinus rhythm.
  • This aggressive approach leads to a substantial reduction in hospital admissions, improving overall patient management.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...